Plaintiffs Seek Invokana MDL For Kidney Injury, Ketoacidosis Injuries

(September 23, 2016, 2:00 PM EDT) -- WASHINGTON, D.C. — Plaintiffs in 29 Invokana kidney injury cases on Sept. 20 filed a motion asking the Judicial Panel on Multidistrict Litigation to centralize theirs and at least 27 other cases in the U.S. District Court for the District of New Jersey (In Re: Invokana [Canagliflozin] Products Liability Litigation, MDL Docket No. n/a, JPMDL).

(Motion available. Document #28-161006-013M.)

Invokana is an oral prescription drug used to help lower blood glucose in patients with type 2 diabetes. The drug was approved in 2013, and in 2016...
To view the full article, register now.